COUNTERACT NOS
Updated 662 days ago
CounterAct is seeking drug development partners to advance this novel technology to save lives and mitigate the Opioid Overdose Epidemic...
CounterAct has developed a US patented, Nasal Delivery Device that snaps on top of any bottle of prescription medicine. Underneath the outer cap is a nasal delivery system consisting of a stowed nasal nozzle that can be extended and inserted into a nostril in the event of an opioid overdose. With minimal pressure, the spring-loaded trigger can be pushed and the rescue medication can be nasally administered.
Also known as: CounterAct